Physician profile
Raluca Dima
NPI 1700520293
$2,777.20
in general payments reported to CMS, 2019-2025
8 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,200 · 2023: $448 · 2024: $795 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,577.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reel Surgical, INC. | $1,222.18 | 2022-2023 | |
| Stryker Corporation | $811.59 | 2023-2024 | Citrefix, Ortholoc 3di, Variax |
| Smith+Nephew, INC. | $294.13 | 2023-2025 | Panta 2, Versajet, Maverick |
| Arthrex, INC. | $143.30 | 2025 | |
| Linvatec Corporation | $142.66 | 2023 | Allograft Tissue |
| Medtronic, INC. | $69.65 | 2024-2025 | In.Pact Admiral, Intellis Adaptivestim |
| International Life Sciences | $47.31 | 2024 | Flexband |
| Zimvie INC. | $46.38 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raluca Dima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.